Form 4 for GALT GALECTIN THERAPEUTICS INC
Accepted 2022-10-31 00:00:00 ET · period of report 2022-10-28 · accession 0001133416-22-000093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-10-31 | 2022-10-28 | GALT | FREEMAN KEVIN D | Dir | P - Purchase | $1.41 | +10.0K | 75.0K | +15% | +$14.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-28 | P | A | 10,000 | $1.41 | 75,000 | I By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC | — | — | (F1) Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |